Cargando…
Biological Characterization of 8-Cyclopropyl-2-(pyridin-3-yl)thiazolo[5,4-f]quinazolin-9(8H)-one, a Promising Inhibitor of DYRK1A
Dual-specificity tyrosine phosphorylation-regulated kinases (DYRKs) hyperactivity has been linked to the development of a number of human malignancies. DYRK1A is the most studied family member, and the discovery of novel specific inhibitors is attracting considerable interest. The 8-cyclopropyl-2(py...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958357/ https://www.ncbi.nlm.nih.gov/pubmed/31861110 http://dx.doi.org/10.3390/ph12040185 |
_version_ | 1783487394988687360 |
---|---|
author | Fruit, Corinne Couly, Florence Bhansali, Rahul Rammohan, Malini Lindberg, Mattias F. Crispino, John D. Meijer, Laurent Besson, Thierry |
author_facet | Fruit, Corinne Couly, Florence Bhansali, Rahul Rammohan, Malini Lindberg, Mattias F. Crispino, John D. Meijer, Laurent Besson, Thierry |
author_sort | Fruit, Corinne |
collection | PubMed |
description | Dual-specificity tyrosine phosphorylation-regulated kinases (DYRKs) hyperactivity has been linked to the development of a number of human malignancies. DYRK1A is the most studied family member, and the discovery of novel specific inhibitors is attracting considerable interest. The 8-cyclopropyl-2(pyridin-3-yl)thiazolo[5,4-f]quinazolin-9(8H)-one (also called FC162) was found to be a promising inhibitor of DYRK1A and was characterized in biological experiments, by western transfer and flow cytometry on SH-SY5Y and pre-B cells. Here, the results obtained with FC162 are compared to well-characterized known DYRK1A inhibitors (e.g., Leucettine L41 and EHT1610). |
format | Online Article Text |
id | pubmed-6958357 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-69583572020-01-23 Biological Characterization of 8-Cyclopropyl-2-(pyridin-3-yl)thiazolo[5,4-f]quinazolin-9(8H)-one, a Promising Inhibitor of DYRK1A Fruit, Corinne Couly, Florence Bhansali, Rahul Rammohan, Malini Lindberg, Mattias F. Crispino, John D. Meijer, Laurent Besson, Thierry Pharmaceuticals (Basel) Communication Dual-specificity tyrosine phosphorylation-regulated kinases (DYRKs) hyperactivity has been linked to the development of a number of human malignancies. DYRK1A is the most studied family member, and the discovery of novel specific inhibitors is attracting considerable interest. The 8-cyclopropyl-2(pyridin-3-yl)thiazolo[5,4-f]quinazolin-9(8H)-one (also called FC162) was found to be a promising inhibitor of DYRK1A and was characterized in biological experiments, by western transfer and flow cytometry on SH-SY5Y and pre-B cells. Here, the results obtained with FC162 are compared to well-characterized known DYRK1A inhibitors (e.g., Leucettine L41 and EHT1610). MDPI 2019-12-17 /pmc/articles/PMC6958357/ /pubmed/31861110 http://dx.doi.org/10.3390/ph12040185 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Fruit, Corinne Couly, Florence Bhansali, Rahul Rammohan, Malini Lindberg, Mattias F. Crispino, John D. Meijer, Laurent Besson, Thierry Biological Characterization of 8-Cyclopropyl-2-(pyridin-3-yl)thiazolo[5,4-f]quinazolin-9(8H)-one, a Promising Inhibitor of DYRK1A |
title | Biological Characterization of 8-Cyclopropyl-2-(pyridin-3-yl)thiazolo[5,4-f]quinazolin-9(8H)-one, a Promising Inhibitor of DYRK1A |
title_full | Biological Characterization of 8-Cyclopropyl-2-(pyridin-3-yl)thiazolo[5,4-f]quinazolin-9(8H)-one, a Promising Inhibitor of DYRK1A |
title_fullStr | Biological Characterization of 8-Cyclopropyl-2-(pyridin-3-yl)thiazolo[5,4-f]quinazolin-9(8H)-one, a Promising Inhibitor of DYRK1A |
title_full_unstemmed | Biological Characterization of 8-Cyclopropyl-2-(pyridin-3-yl)thiazolo[5,4-f]quinazolin-9(8H)-one, a Promising Inhibitor of DYRK1A |
title_short | Biological Characterization of 8-Cyclopropyl-2-(pyridin-3-yl)thiazolo[5,4-f]quinazolin-9(8H)-one, a Promising Inhibitor of DYRK1A |
title_sort | biological characterization of 8-cyclopropyl-2-(pyridin-3-yl)thiazolo[5,4-f]quinazolin-9(8h)-one, a promising inhibitor of dyrk1a |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958357/ https://www.ncbi.nlm.nih.gov/pubmed/31861110 http://dx.doi.org/10.3390/ph12040185 |
work_keys_str_mv | AT fruitcorinne biologicalcharacterizationof8cyclopropyl2pyridin3ylthiazolo54fquinazolin98honeapromisinginhibitorofdyrk1a AT coulyflorence biologicalcharacterizationof8cyclopropyl2pyridin3ylthiazolo54fquinazolin98honeapromisinginhibitorofdyrk1a AT bhansalirahul biologicalcharacterizationof8cyclopropyl2pyridin3ylthiazolo54fquinazolin98honeapromisinginhibitorofdyrk1a AT rammohanmalini biologicalcharacterizationof8cyclopropyl2pyridin3ylthiazolo54fquinazolin98honeapromisinginhibitorofdyrk1a AT lindbergmattiasf biologicalcharacterizationof8cyclopropyl2pyridin3ylthiazolo54fquinazolin98honeapromisinginhibitorofdyrk1a AT crispinojohnd biologicalcharacterizationof8cyclopropyl2pyridin3ylthiazolo54fquinazolin98honeapromisinginhibitorofdyrk1a AT meijerlaurent biologicalcharacterizationof8cyclopropyl2pyridin3ylthiazolo54fquinazolin98honeapromisinginhibitorofdyrk1a AT bessonthierry biologicalcharacterizationof8cyclopropyl2pyridin3ylthiazolo54fquinazolin98honeapromisinginhibitorofdyrk1a |